Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jan 18;14(2):173.
doi: 10.3390/v14020173.

Molecular Epidemiology of Norovirus (NoV) Infection in Mie Prefecture: The Kinetics of Norovirus Antigenemia in Pediatric Patients

Affiliations

Molecular Epidemiology of Norovirus (NoV) Infection in Mie Prefecture: The Kinetics of Norovirus Antigenemia in Pediatric Patients

Jennifer X Amexo et al. Viruses. .

Abstract

Few studies have shown the presence of norovirus (NoV) RNA in blood circulation but there is no data on norovirus antigenemia. We examined both antigenemia and RNAemia from the sera of children with NoV infections and studied whether norovirus antigenemia is correlated with the levels of norovirus-specific antibodies and clinical severity of gastroenteritis. Both stool and serum samples were collected from 63 children admitted to Mie National Hospital with acute NoV gastroenteritis. Norovirus antigen and RNA were detected in sera by ELISA and real-time RT-PCR, respectively. NoV antigenemia was found in 54.8% (34/62) and RNAemia in 14.3% (9/63) of sera samples. Antigenemia was more common in the younger age group (0-2 years) than in the older age groups, and most patients were male. There was no correlation between stool viral load and norovirus antigen (NoV-Ag) levels (rs = -0.063; Cl -0.3150 to 0.1967; p = 0.6251). Higher levels of acute norovirus-specific IgG serum antibodies resulted in a lower antigenemia OD value (n = 61; r = -0.4258; CI -0.62 to -0.19; p = 0.0006). Norovirus antigenemia occurred more commonly in children under 2 years of age with NoV-associated acute gastroenteritis. The occurrence of antigenemia was not correlated with stool viral load or disease severity.

Keywords: ELISA; RNAemia; antigenemia; norovirus; real-time RT-PCR.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Viral load estimation from RT-qPCR and its correlation with NoV-Ag levels in serum and stool samples. (A) The red square dots represent positive serum samples, the dotted blue triangles represent positive stool samples without RNA present in their serum, and the circular green dots represent positive stool samples with RNA present in the serum. (B) Correlation between positive stool and antigenemia based on serum OD at 450 nm. ** p < 0.01, *** p < 0.001.
Figure 2
Figure 2
NoV IgG titration curves in serum samples from acute infections. (A) Sera from children with GII.4 Sydney/2012 (black lines, n = 21) and GI.2 genotype (green line, n = 2). (B) Other GII genotypes (red lines, n = 14) were titrated with two-fold serial dilutions, and IgG antibodies were analyzed against GII.4 Ni 1315 and GII.17 Kawasaki-308 genotypes. For GII.17 Kawasaki-308, (C) black lines, n = 17; green lines, n = 2; and (D) red lines, n = 12.
Figure 3
Figure 3
NoV pre-existing antibody titer responses for different age groups. * p < 0.05, ns: not significant.
Figure 4
Figure 4
Correlation of antigenemia to serum acute antibody titers.
Figure 5
Figure 5
Phylogenetic analyses generated by the maximum likelihood test using the partial nucleotide sequences (338, 302, and 342 bp) from the C region of the capsid of norovirus. The strains reported in this study are indicated with a blue circle (stool) and a red triangle (sera).

Similar articles

References

    1. Rha B., Lopman B.A., Alcala A.N., Riddle M.S., Porter C.K. Incidence of Norovirus-Associated Medical Encounters among Active Duty United States Military Personnel and Their Dependents. PLoS ONE. 2016;11:e0148505. doi: 10.1371/journal.pone.0148505. - DOI - PMC - PubMed
    1. Cannon J.L., Bonifacio J., Bucardo F., Buesa J., Bruggink L., Chan M.C., Fumian T.M., Giri S., Gonzalez M.D., Hewitt J., et al. Global Trends in Norovirus Genotype Distribution among Children with Acute Gastroenteritis. Emerg. Infect. Dis. 2021;27:1438–1445. doi: 10.3201/eid2705.204756. - DOI - PMC - PubMed
    1. Glass R.I., Parashar U.D., Estes M.K. Norovirus gastroenteritis. N. Engl. J. Med. 2009;361:1776–1785. doi: 10.1056/NEJMra0804575. - DOI - PMC - PubMed
    1. Lun J.H., Hewitt J., Yan G.J.H., Enosi Tuipulotu D., Rawlinson W.D., White P.A. Recombinant GII.P16/GII.4 Sydney 2012 Was the Dominant Norovirus Identified in Australia and New Zealand in 2017. Viruses. 2018;10:548. doi: 10.3390/v10100548. - DOI - PMC - PubMed
    1. Siebenga J.J., Vennema H., Zheng D.P., Vinje J., Lee B.E., Pang X.L., Ho E.C., Lim W., Choudekar A., Broor S., et al. Norovirus illness is a global problem: Emergence and spread of norovirus GII.4 variants, 2001–2007. J. Infect. Dis. 2009;200:802–812. doi: 10.1086/605127. - DOI - PubMed

Publication types

MeSH terms